For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

In his inaugural lecture, Bart Biemond considers the impact of sickle cell disease. Each year, this hereditary form of anaemia is diagnosed in an estimated 300,000 to 400,000 newborn babies worldwide.

Event details of The impact of sickle cell disease
Date 5 September 2019
Time 16:00
Location Aula - Lutherse kerk
Prof Bart Biemond
Bart Biemond (photo: Dirk Gillissen)

The disease is characterised by chronic anaemia and painful crises caused by vascular occlusion by abnormally formed red blood cells (sickle cells). The disease leads to many complications and a greatly reduced life expectancy. In the Netherlands, an estimated 1,500 to 2,000 people suffer from this disease, which mainly occurs in people originally from Africa, the Middle East, Asia or southern Europe.

Biemond will describe the impact of sickle cell anaemia on children and adults, and explain new knowledge and the resulting new treatment methods for this serious condition.

Dr B.J. Biemond, Professor of Internal Medicine: Sikkel en de Zeis.


This event is open to the public.

Aula - Lutherse kerk

Singel 411
1012 XM Amsterdam